Should we, can we, halt the rise in prescribing for pain and distress?-Reference-Cited by-同舟云学术

Should we, can we, halt the rise in prescribing for pain and distress?

Published:2020-08-27 Issue:698 Volume:70 Page:432-433
ISSN:0960-1643
Container-title:British Journal of General Practice
language:en
Short-container-title:Br J Gen Pract

Author:

Byng Richard

Publisher

Royal College of General Practitioners

Subject

Family Practice

Reference16 articles.

1. Public Health England (PHE) Dependence and withdrawal associated with some prescribed medications: an evidence review PHE 2019

2. NHS Digital Prescription cost analysis — England, 2017 [PAS] NHS Digital 2018

3. Exasol Exasol analyzes: research shows that over 64m prescriptions of antidepressants are dispensed per year in England Exasol 2017

4. The psychoactive effects of psychiatric medication: the elephant in the room;Moncrieff;J Psychoactive Drugs,2013

5. Whitaker R Anatomy of an epidemic: magic bullets, psychiatric drugs, and the astonishing rise of mental illness in America New York, NY Crown Publishers 2020

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Safe Deprescribing of Gabapentinoids;The Maudsley Deprescribing Guidelines – Antidepressants, Benzodiazepines, Gabapentinoids and Z‐drugs;2024-08-30

2. Introduction to Deprescribing Psychiatric Medications;The Maudsley Deprescribing Guidelines – Antidepressants, Benzodiazepines, Gabapentinoids and Z‐drugs;2024-08-23

3. Designing withdrawal support services for antidepressant users: Patients’ views on existing services and what they really need;Journal of Psychiatric Research;2023-05

4. NICE chronic primary pain guidelines: what the busy GP needs to know;British Journal of General Practice;2022-04-28

5. Should I, can I, dare I? Patients’ view on stopping long-term antidepressant use, a qualitative study;Acta Clinica Belgica;2022-01-10